23 results
Thumbnail

D2.134 - Transitioning adolescents and young adults with asthma: insights from a severe asthma series

Thumbnail

D2.133 - Clinical and Direct Medical Burden of Hospitalized Children with Asthma Exacerbations

Thumbnail

D2.135 - What are our children breathing? Tracking exposure to air pollution during a school day

Thumbnail

D2.136 - Nasal transcriptomics as a biomarker for ICS/LABA treatment in paediatric asthma in the PUFFIN study

Thumbnail

D2.137 - Long term, Persistent Eosinophilia in patients with Asthma and CRSwNP undergoing Dupilumab therapy: preliminar results of a 24-month follow up prospective study

Thumbnail

D2.138 - The Effect of Human Milk Oligosaccharides 2’FL and 3FL on Macrophage polarization

Thumbnail

D2.139 - Oxidative stress and tissue hypoxia are triggered through the increased respiratory effort during sleep and reflect the inflammation as a stress link in the gut-brain axis in children suffering asthma, allergic/non-allergic rhinitis, and/or eczema

Thumbnail

D2.140 - Allergic Sensitization Patterns in Western Romania: Impact of Airborne Allergens and Climate Factors

Thumbnail

D2.142 - Smoking cessation advice to parents in children with bronchial asthma- still it is a long way to go

Thumbnail

D2.144 - Occupational Asthma due to garlic powder: a case report

Thumbnail

D2.145 - The utility of blood eosinophils, IgE and skin prick testing in paediatric asthma diagnosis

Thumbnail

D2.146 - Occupational Asthma due to Subtilisin: the power of specific inhalation challenge

Thumbnail

D2.147 - Comparison of clinical outcomes with Benralizumab in severe eosinophilic asthma: Switched and naïve patients

Thumbnail

D1.370 - Clinical outcomes and quality of life improvement in children with moderate-to-severe atopic dermatitis and atopic multimorbidity treated with dupilumab

Thumbnail

D1.362 - Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab

Thumbnail

D1.363 - Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis

Thumbnail

D1.364 - Update on the Observed incidence of Anaphylaxis and Serum Sickness in Patients Receiving Omalizumab in a Canadian Tertiary Allergy/Asthma Clinic

Thumbnail

D1.365 - ZL-1503: A Bispecific Antibody Targeting Inflammatory and Pruritogenic Pathways with a Prolonged Serum Half-life and Sustained Activity in Non-human Primates

Thumbnail

D1.366 - Improvement Over Time in Specific Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab

Thumbnail

D1.367 - Dupilumab for refractory pruritus in hematological and non-hematological malignancies – preliminary results